Skip to main content
. 2011 Jul;165(1):19–28. doi: 10.1111/j.1365-2249.2011.04392.x

Fig. 5.

Fig. 5

Effect of antibody treatment during the chronic challenge period on immunoreactivity for active transforming growth factor (TGF)-β1. Intensity of staining (a) in the epithelium and (b) in the subepithelial zone, in animals treated with anti-interleukin (IL)-4 or anti-IL-25 during the chronic challenge period. Significant differences compared to naive animals shown as *P < 0·05.